Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Ready Capital Corporation Announces First Quarter 2024 Results and Webcast Call
-
FinWise Bancorp Reports First Quarter 2024 Results
-
National Down Syndrome Society to Host Acoustic Performance by GRAMMY® Award-winning Band Creed as Part of Charity Golf Outing
-
NXP Semiconductors Reports First Quarter 2024 Results
-
Amalgamated Financial Corp. Announces Completion of Three Oregon Community Solar Program Projects
-
Navios Maritime Partners L.P. Announces Cash Distribution of $0.05 per Unit
-
Applied Optoelectronics Announces Equity Grants To Employees Under Inducement Plan
-
Woodward Reports Second Quarter Fiscal Year 2024 Results
-
MYR Group Inc. to Attend Baird Global Consumer, Technology & Services Investor Conference in June
-
The Simply Good Foods Company to Acquire Only What You Need (OWYN)
-
Lucas Announces Fiscal Year 2023 Financial Results with 92.3% Growth, Reaching Revenue at $208M
-
Lantronix Reports Record Revenue for Third Quarter of Fiscal 2024
-
Pathfinder Bancorp, Inc. Announces First Quarter 2024 Net Income of $2.1 Million
-
Pool Corporation to Present at the Oppenheimer 19th Annual Industrial Growth Conference
-
Ekso Bionics Announces First Quarter 2024 Financial Results
-
Oculis Publishes Invitation to the Annual General Meeting
-
James River To Hold Its First Quarter Earnings Conference Call on Thursday, May 9, 2024
-
QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance
-
Terns Pharmaceuticals Announces Data from Ongoing Phase 1 Pharmacokinetic Study of Allosteric BCR-ABL Inhibitor TERN-701 in Adult Healthy Volunteers and Highlights Potential for Competitive Differenti
-
ACELYRIN, INC. to Report First Quarter 2024 Financial Results and Corporate Update on May 13, 2024
-
Nature’s Sunshine Recognized with Six Stevie Awards in the 2024 American Business Awards
-
Option Care Health to Participate in the BofA Securities Health Care Conference
-
GeneDx Reports First Quarter 2024 Financial Results and Business Highlights
-
Safe Bulkers, Inc. Reports First Quarter 2024 Results and Declares Dividend on Common Stock
-
OpGen Provides Update on Business Operations and Strategic Opportunities
-
Inotiv, Inc. to Report Fiscal 2024 Second Quarter Financial Results and Host Conference Call on Friday, May 10, 2024
-
Gibson Energy Declares Dividend
-
Kforce Reports First Quarter 2024 Revenue of $351.9 Million and EPS of $0.58
-
Astec Announces Quarterly Dividend
-
Gibson Energy Announces 2024 First Quarter Results and Record Volumes at Gateway Terminal
-
Cansortium Reports Fourth Quarter and Full Year 2023 Results
-
Metawells Oil & Gas Inc. Releases Current Updates
-
Metawells Oil & Gas Inc. Releases Current Updates
-
Clean Energy Special Situations Corp. Receives Notice from Nasdaq Regarding Suspension of Trading of Securities and Plans to File for Hearing
-
Teknova to Report First Quarter 2024 Financial Results on May 13, 2024
-
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Maxim Group Expands its Fixed Income Group with the Addition of Stephen Read, Mark Koontz, and Tim Reilly
-
Citizens Community Bancorp, Inc. Reports First Quarter 2024 Earnings of $0.39 Per Share; Nonperforming Assets Decreased 31%; Criticized Assets Decreased 25%
-
Cytokinetics to Host Investor Event and Conference Call to Discuss the Primary Results From SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress
-
Byline Bank Highlights Small Business Borrowers During National Small Business Week
-
Arcutis to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
-
Columbus Recognized with Six USA Today 10Best Readers' Choice Awards
-
Columbus Recognized with Six USA Today 10Best Readers' Choice Awards
-
Lleida.net recovers in the first quarter of 2024 with a 71% increase in EBITDA, up to 666,000 euros
-
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Exscientia
-
Nokia Corporation: Repurchase of own shares on 29.04.2024
-
Lleida.net reports losses of 2.65 million euros and a 20% drop in sales in 2023
-
Pediatric Brain Tumor Foundation celebrates FDA approval of Day One Biopharmaceuticals’ OJEMDA™, new treatment for common pediatric brain tumor type
-
Rivers Agency Launches Dynamic New Website
-
Bavarian Nordic Receives 65 mEUR Contract to Supply Smallpox Vaccines for EU Strategic Reserve


